Live News EQUITY FLASH L impact Oct 30, 2026, 11:22 AM UTC Goldman Sachs downgrades Bicara Therapeutics to Sell, sets $8 target Valid market news retained in the public archive without immediate LiveCast distribution. BCAX SquawkNews Desk